Most vulnerable still in jeopardy as COVID precautions ease

  • Ray Hoffman, who is immune-compromised, holds a photo of himself taken in 2020 when he received a liver transplant on Jan. 20 after he was given a two-shot dose of AstraZeneca’s Evusheld, the first set of antibodies grown in a lab to prevent COVID-19, at a University of Washington Medicine clinic in Seattle. The drug is supposed to give patients like Hoffman, who can’t make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Two years into the pandemic Jackie Hansen still left home only for doctor visits, her immune system so wrecked by cancer and lupus that COVID-19 vaccinations couldn’t take hold.